Interestingly, while HO-1 inhibition exerts anti-tumor effects, carbon monoxide (CO), a product of HO-1 activity, has also been reported to exhibit anti-tumor properties (65, 66) and to stimulate CD8+ T-cell responses (67). The gene discussed is CD8A; the disease is neoplasm.